We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Hillstream BioPharma Inc (HILS) USD0.0001

Sell:$0.75 Buy:$0.82 Change: $0.0255 (3.15%)
Market closed |  Prices as at close on 6 July 2022 | Switch to live prices |
Change: $0.0255 (3.15%)
Market closed |  Prices as at close on 6 July 2022 | Switch to live prices |
Change: $0.0255 (3.15%)
Market closed |  Prices as at close on 6 July 2022 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Hillstream BioPharma, Inc. (HBI) is a pre-clinical biotechnology company. The Company is engaged in developing therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) for treatment of resistant cancers. Its lead product candidate is HSB-1216, an IMCD modulator, targeting a variety of solid tumors. The drug, HSB-1216 was found to reduce tumor burden treatment resistant cancers, including triple negative breast cancer and epithelial carcinomas. The Company uses Quatramer, a tumor targeting platform to treat rare and treatment resistant cancers. Its Trident Artificial Intelligence, an artificial intelligence precision medicine platform, is used to identify biomarkers in clinical programs to target specific patient segments. HBI's second second product candidate, HSB-888, is a dual-loaded Iron Medicated Cell Death modulator for solid tumors. Its other product candidates are HSB-510 and HSB-114.

Contact details

1200 Route 22 East, Suite 2000
United States
+1 (908) 9553140

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$9.16 million
Shares in issue:
11.60 million
United States
US dollar

Key personnel

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.